Interrelationship of extent of precocious adrenarche in appropriate for gestational age girls with clinical outcome

Tal Oron*, Yael Lebenthal, Liat De Vries, Michal Yackobovitch-Gavan, Moshe Phillip, Liora Lazar

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


Objective: To assess the interrelationship between extent of adrenarche at presentation in girls with precocious adrenarche (PA) born appropriate for gestational age and their growth pattern, pubertal course and adult height. Study design: We reviewed clinical and laboratory data from medical charts of 85 girls with PA aged 5.0 to 8.8 years at referral, stratified in 3 subgroups according to bone age (BA) minus chronological age (CA) ≤0 years; 0 <BA minus CA <1 year; BA minus CA >1 year. Results: Extent of pubarche and dehydroepiandrosterone-sulfate levels were greatest in the BA-CA >1 subgroup (P =.02, P =.008, respectively), who also were taller at diagnosis (P =.002) and during childhood (P =.01). In all subgroups, pubertal onset was within normal range; menarche occurred earlier than in control subjects (P <.02); all attained adult height within their mid-parental height range. Predicted adult height was overestimated in girls with BA ≤CA (P =.04) and underestimated with BA-CA >1 (P <.001). Conclusions: Although a more pronounced adrenarche and BA advancement at diagnosis in girls with PA born appropriate for gestational age had an impact on their pre-pubertal growth pattern, it was not associated with early and rapid progression of puberty or reduced adult height. This reassuring clinical course indicates that PA is a benign condition, irrespective of the extent of adrenarche at presentation. Adult height prediction is unreliable in PA.

Original languageEnglish
Pages (from-to)308-313
Number of pages6
JournalJournal of Pediatrics
Issue number2
StatePublished - Feb 2012


Dive into the research topics of 'Interrelationship of extent of precocious adrenarche in appropriate for gestational age girls with clinical outcome'. Together they form a unique fingerprint.

Cite this